Exscientia — AI-driven drug design (Centaur Chemist, EVE); acquired by Recursion Pharmaceuticals Nov 2024
open-source machine-learning computational-chemistry drug-discovery drug-design precision-medicine oncology biotech pharmaceuticals acquired small-molecules generative-chemistry ai-drug-design centaur-chemist eve-platform patient-derived-screening
-
Updated
May 25, 2026